Wisconsin Roundup: Exact Sciences, CSA Partners, 100state, & More

Xconomy Wisconsin — 

In this week’s installment of Wisconsin innovation headlines, startups are raising capital, co-working spaces are on the move, and a closely watched Madison life sciences company offers details about initial commercialization of its FDA-approved product:

—Cellectar Biosciences (NASDAQ: CLRB) raised $13.5 million in its first public offering since moving to the Nasdaq stock exchange from being traded over the counter. That’s $1 million more than the Madison biotech startup projected. Read more about Cellectar’s move to the Nasdaq in this Xconomy profile.

Intuitive Biosciences raised nearly $500,000 in debt funding, according to an SEC document. The Fitchburg-based company makes diagnostics tools for animal research. It previously raised more than $572,000 from investors, an SEC document shows.

Microscopy Innovations, a Marshfield-based company that makes tools for microscopy labs, raised $410,000 from investors, an SEC filing shows.

—CSA Partners, the $10 million micro-venture capital fund backed by Milwaukee County Executive Chris Abele, is starting a for-profit co-working space in the Historic Pritzlaff Building near downtown Milwaukee, according to a Milwaukee Journal Sentinel article. “Ward 4” will feature 35,000 square feet to house startups, service providers, and CSA. The initiative will be located in the same building where the weekly 1 Million Cups chats take place, a national event series brought to Milwaukee by CSA Partners and others.

—In other co-working space news, 100state plans to move its Madison office across the street, leaving 100 State St. in September for bigger digs at 30 W. Mifflin St., according to Madison Startups. 100state will be located a floor above startup accelerator Gener8tor’s office. Gener8tor also has a location in Milwaukee.

—Madison-based Exact Sciences (NASDAQ: EXAS) announced that the Mayo Clinic will be the first healthcare system to offer patients Cologuard, Exact’s newly approved, stool-based DNA screening test for colorectal cancer. Researchers at Rochester, MN-based Mayo Clinic helped Exact develop the test.

—Last month, green roof startup Vegetal i.D. launched its pilot storm water management program in Milwaukee. Xconomy profiled the company in January as part of its series on companies that participated in The Water Council’s inaugural startup accelerator in the Global Water Center.